The ASH Medical Educators Institute, New Podcasts, and more

ASH’s new Medical Educators Institute (MEI) provides hematologists who are new to medical education careers a “boot camp” in teaching techniques, fundamentals of medical education research, and career-development essentials. This competitive training and mentoring program is modeled after ASH’s highly successful Clinical Research Training Institute in which participants learn from experts and interact with similarly inclined faculty in a focused, intensive, small-group setting. Over the course of the three-day workshop at ASH Headquarters in Washington, DC, participants will be given the tools they need to excel as educators and role models at their own institutions and will develop and complete a scholarly project in hematology education over the year following the program with the help of an assigned mentor.

Some of the topics to be covered during the workshop include: active learning modalities, educational research design, learner assessment and feedback, development of multiple-choice questions, use of technology, and medical education financing.

Costs for travel to the program, lodging, and meals will be covered by ASH. The application will be available until April 22, 2016.

Marc J. Kahn, MD, MBA, from Tulane University, and Jennifer Kesselheim, MD, from Boston Children’s Hospital and Dana-Farber Cancer Institute are serving as the co-chairs for the inaugural program. Other faculty include:

  • Mark P. Atlas, MD, Hofstra Northwell School of Medicine
  • Linda J. Burns, MD, National Marrow Donor Program
  • Leslie Ellis, MD, Wake Forest University
  • Scott Gitlin, MD, University of Michigan
  • Erin Gormley Reid, MD, University of California, San Diego
  • Alice Ma, MD, University of North Carolina
  • Roy Smith, MD, University of Pittsburgh
  • Kenneth Zuckerman, MD, University of South Florida Moffit Cancer Center
  • Marc Zumberg, MD, University of Florida

For more information, including the preliminary program schedule, eligibility requirements, and application instructions, click here.


Available on ASH On Demand

Webcasts from the 57th ASH Annual Meeting are available through ASH On Demand (www.ashondemand.org). This year’s annual meeting webcast offers nearly 100 hours of recorded annual meeting content including: General Sessions, Special-Interest Sessions, Trainee Simultaneous Didactic Sessions, Education Program Sessions, Education Spotlight Sessions, Scientific Program Sessions (new), Special Scientific Symposia (new), and Scientific Spotlight Sessions (new). For access to these webcasts, click here.


New Podcast Focuses on TWiTCH Trial

In this latest podcast, based on content in The Hematologist: ASH News and Reports, Russell Ware, MD, PhD, from the University of Cincinnati and Cincinnati Children’s Hospital, and Michael DeBaun, MD, MPH, from Vanderbilt University School of Medicine, have a conversation about the “TCD With Transfusions Changing to Hydroxyurea,” or “TWiTCH,” Trial — a multicenter, open-label, phase III, non-inferiority trial. The trial compares hydroxyurea with standard transfusions used to treat children with sickle cell disease and high transcranial Doppler (TCD) flow velocities.

Visit soundcloud.com/ash_hematology to listen to this program and to see a list of past podcasts available. Listeners can also download the SoundCloud mobile app from the Google Play or App Store to listen on their mobile device.


ASH Webinar on Using Eltrombopag for the Treatment of Children With ITP

The first webinar of 2016 will allow participants to listen to presentations by a U.S. Food and Drug Administration (FDA) expert, Lori A. Ehrlich, MD, PhD, medical officer, Division of Hematology Products, HOP/OND/CDER/FDA, and a clinician, Ellis J. Neufeld, MD, PhD, associate chief, Division of Hematology/Oncology, Egan Family Foundation Chair in Transitional Medicine, Boston Children’s Hospital, Harvard Medical School, on the new indication of a previously approved agent, eltrombopag, in the treatment of children six years and older with chronic immune thrombocytopenia (ITP).

Tune in live on Thursday, February 11, 2016, at 2:00 p.m. Eastern Time to hear a discussion led by moderator, Cindy Neunert, MD MSCS, of Columbia University Medical Center.

There will be time for speakers and participants to discuss relevant issues during a question-and-answer session. Visit the ASH website (www.hematology.org/Education/Webinars.aspx) for more information and to register. ASH webinars are archived on ASH On Demand (www.ashondemand.org).

SHARE